Chongqing Saiwei Pharmaceutical

Chongqing Saiwei Pharmaceutical is a Chinese pharmaceutical company focused on the development, manufacturing, and commercialization of high-quality generic drugs and active pharmaceutical ingredients (APIs). Headquartered in the Chongqing International Biological City, the company has established a significant presence in the ophthalmic market, particularly with its range of prostaglandin analogue eye drops for glaucoma. Beyond ophthalmology, Saiwei maintains a robust portfolio in cardiovascular, endocrine, and anti-infective therapeutic areas. The firm operates GMP-certified production lines and emphasizes vertical integration from API synthesis to finished dosage forms. Its products are distributed widely across the Chinese domestic market, supporting its position as a key regional player in the life sciences sector.